Tag - medicine-4

 
Menu
Search
 
July 28, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE 4

Japan Times
WORLD / Science & Health
Jan 7, 2023
Alzheimer’s drug made jointly by Japan's Eisai wins accelerated U.S. approval
The U.S. has called the drug 'an important advancement in the ongoing fight' against the debilitating disease. But its $26,000 price tag could put it out of reach for many.
Japan Times
ASIA PACIFIC
Jan 7, 2023
China’s COVID surge threatens villages as Lunar New Year approaches
China is bracing for an onslaught of infections in its fragile countryside as millions of people crowd onto trains and buses to return to their rural homes for the Lunar New Year holiday.
Japan Times
ASIA PACIFIC / Science & Health
Jan 7, 2023
China in talks with Pfizer for generic COVID drug
Beijing is in talks with the drugmaker to secure a license that will allow domestic firms to manufacture and distribute a generic version of its Paxlovid antiviral drug.
Japan Times
COMMENTARY / World
Jan 6, 2023
No, vaccines aren’t making new COVID-19 variants worse
The omicron sequel XBB.1.5 is driving a new wave of COVID-19 infections — and misinformation.
Japan Times
COMMENTARY / World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
WORLD
Dec 30, 2022
Dressing 'revolution' seeks artificial skin for burn victims
New developments have shaken up the world of wound healing, long a neglected area of medical research.
Japan Times
ASIA PACIFIC
Dec 30, 2022
China's COVID wave sparks scramble for vital drugs across Asia
Beijing's decision to abruptly remove most pandemic restrictions with little preparation is driving an unprecedented number of cases, leaving hospitals and funeral homes overwhelmed.
Japan Times
BUSINESS / Companies
Dec 28, 2022
Tokyo firm targets blood tests for Alzheimer's in wake of therapy breakthrough
Fujirebio Holding is boosting its lineup of reagents used to detect Alzheimer's biomarkers in blood tests.
Japan Times
JAPAN / Science & Health
Dec 25, 2022
Japan medical bodies aim to develop tailored drugs to treat rare diseases
Japanese researchers plan to develop tailored drugs and treatments for patients with extremely rare diseases.
Japan Times
JAPAN
Dec 25, 2022
Doctor-staffed rapid response vehicles in wider use in Japan
By providing treatment to patients before they are taken to hospital, including in the vehicles, medical professionals can respond to sudden changes in their conditions.
Japan Times
JAPAN / Science & Health
Dec 22, 2022
Japan approves blood test to detect Alzheimer’s
Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon.
Japan Times
WORLD / Science & Health
Dec 22, 2022
Injectable HIV treatment offers hope to Ugandan patients
Some hope the new treatment option could help to reduce the stigma HIV patients suffer, particularly gay men.
Japan Times
COMMENTARY / World
Dec 21, 2022
Another Crispr first: New treatment wipes out teen's cancer
Next-generation Crispr gene-editing was used to create a therapy that attacked a 13-year-old's stubborn leukemia.
Japan Times
EDITORIALS
Dec 16, 2022
China’s reopening poses new challenges for itself and the world
The situation in China is likely to get worse with the ending of the 'zero-COVID' policy before it gets better, slowing its economy even more.
Japan Times
JAPAN / Science & Health
Dec 15, 2022
Despite unclear effectiveness, kanpō in short supply amid COVID wave
The widespread use and availability of kanpu014d in Japan has given some people hope that it may work as a viable treatment for the viral disease.
Japan Times
BUSINESS / Companies
Dec 14, 2022
Takeda to pay up to $6 billion for Nimbus immune-therapy drug
After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.
Japan Times
JAPAN / Science & Health
Dec 13, 2022
Shionogi says Japan government to buy 1 million more COVID pill doses
The added supply agreement comes at a time when Japan is dealing with an eighth wave of COVID-19 infections.
Japan Times
BUSINESS
Dec 8, 2022
Ex-Theranos president Ramesh Balwani gets 13-year prison term in fraud case
Balwani and the company's founder, Elizabeth Holmes, had promised to revolutionize the medical industry by using a few drops of blood to complete a wide array of health tests.
Japan Times
WORLD / Science & Health
Dec 6, 2022
Long ICU stays lead to extended misery for many COVID survivors
The mechanical ventilation, anti-inflammatory drugs and other tools of modern medicine that help people beat severe cases of COVID-19 often come with harrowing aftereffects.
Japan Times
COMMENTARY / World
Dec 2, 2022
Amgen has a contender in the weight-loss drug wars
Amgen's obesity drug offers a new twist on proven methods to help people lose unwanted pounds.
Japan's population continues to fall even as foreign resident count rises
The number of residents in Tokyo as of Jan. 1 rose by 0.03% from a year before, data shows, marking a year-on-year increase for the first time in three years, while the country's other 46 prefectures saw their populations continue to decline.
Ahead of the Olympics, Japan is still talking about the gymnast who won't be there
Japan's Shoko Miyata withdrew from the gymnastics team herself over her drinking and smoking, although it had already appeared as though the association was prepared to send her home from the team’s training camp in Monaco.
Yen melt-up nudges Japanese stocks into correction territory
Japanese stocks are down 10% from their July peak as the yen strengthens.
‘Crazy’ yen rally is at risk of shattering as soon as Wednesday
Some investors are warning that a yen rally is fragile, as was on show this week when the yen rapidly retraced an advance after Thursday’s stronger-than-expected U.S. economic growth figures.
Japan's average life expectancy rises for first time in three years
A decline in COVID-19-caused deaths likely helped boost the average life expectancy for Japanese men and women to rise for the first time in three years in 2023.
The Japanese Olympians looking to shine in Paris
Rim Nakamura, who is attempting to win Japan's first Olympic gold medal in cycling, will be one of the top Japanese athletes to watch at the Paris Games.
Japan’s minimum wage set for record ¥50 hike in major boost
Demonstrators rally to demand a big hike in minimum wages in Tokyo last week.
Japan loses top spot on strongest passport list to Singapore
Japan had the strongest passport for six years running from 2018, before being dethroned by Singapore on the 2024 list.
Why Japan's mysterious stash of classified funds escapes scrutiny
Prime Minister Fumio Kishida and Chief Cabinet Secretary Yoshimasa Hayashi (right) during a meeting in Tokyo on Tuesday.
Japan eyes gold — and the future — as Olympic men's soccer campaign begins
Japan midfielder Yu Hirakawa controls the ball during a match against the United States in Kansas City, Kansas, on June 11.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Traditional folk rituals like Mizudome-no-mai (dance to stop the rain) provide a sense of agency to a population that feels largely powerless in the face of the climate crisis.
As climate extremes intensify, Japan embraces ancient weather rituals
By Alex K.T. Martin

SUSTAINABLE JAPAN

JNTO promotes sustainable tourism initiatives
JNTO promotes sustainable tourism initiatives

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER